Cyclacel Pharmaceuticals ... (CYCC)
NASDAQ: CYCC
· Real-Time Price · USD
9.12
0.23 (2.59%)
At close: Aug 15, 2025, 10:09 AM
2.59% (1D)
| Bid | 8.94 |
| Market Cap | 14.44M |
| Revenue (ttm) | -21K |
| Net Income (ttm) | -8.35M |
| EPS (ttm) | 43.2 |
| PE Ratio (ttm) | 0.21 |
| Forward PE | -0.03 |
| Analyst | Buy |
| Ask | 9.25 |
| Volume | 46,580 |
| Avg. Volume (20D) | 1,884,237 |
| Open | 8.91 |
| Previous Close | 8.89 |
| Day's Range | 8.82 - 9.40 |
| 52-Week Range | 3.08 - 597.60 |
| Beta | 0.09 |
About CYCC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CYCC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CYCC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+0.85%
Cyclacel Pharmaceuticals shares are trading lower ...
Unlock content with
Pro Subscription
1 month ago
-26.19%
Cyclacel Pharmaceuticals share are trading lower after the company announced a 1-for-15 reverse stock split.
